TORONTO, Feb. 11, 2021 / PRNewswire / – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a high-quality cannabis supplier, today announced that leading independent voting consultancy, Institutional Shareholder Services (“ISS”), recommends that Liberty shareholders vote “FOR” the shareholder proposal relating to Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr”) proposed to acquire Liberty Health Sciences.
In its February 9, 2021 report, ISS said: Vote “FOR” this proposal based on a review of the terms of the transaction, in particular, the significant premium, favorable market response and reasonable strategic justification.
“We are pleased that ISS shares our belief that the transaction we have proposed is good for Liberty shareholders and supports the recommendation of the Liberty Board to vote ‘FOR’ the proposed acquisition by Ayr,” said George Gremse, CEO acting and director of Liberty. “Together, Ayr and Liberty will be a competitive force in Florida.”
On December 22, 2020, Ayr announced the proposed acquisition of Liberty as part of a share-for-share combination. Freedom…
Check Additional From Source
Copyright @ www.prnewswire.com
News Highlights Science
- According to the source ISS recommends that Liberty Health Science shareholders vote “FOR” the proposed acquisition by Ayr
- Check all news and articles from the Science news information updates.